Balyasny Asset Management
SBRA icon

Balyasny Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Balyasny Asset Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150,000
Closed -$1.64M – 1449
2020
Q1 		$1.64M Buy
+150,000
New +$2.77M 0.02% 654

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Balyasny Asset Management's SBRA Position: Q2 2026 in Review

Balyasny Asset Management increased its Sabra Healthcare REIT (SBRA) stake by 279% in Q2 2026, buying an estimated $775K and bringing the position to 53,074 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

Balyasny Asset Management first reported a position in SBRA in Q2 2013 and has held it in 29 quarters since. The position peaked at $50M in Q2 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Balyasny Asset Management held 53,074 shares of Sabra Healthcare REIT worth $1.04M as of Q2 2026.
  • Balyasny Asset Management bought 39,070 Sabra Healthcare REIT shares in Q2 2026, an estimated $775K.
  • Sabra Healthcare REIT made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2190 holding.
  • Balyasny Asset Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 29 quarters since.
  • Balyasny Asset Management's Sabra Healthcare REIT position peaked at $50M in Q2 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.